home / stock / opti:cc / opti:cc news

OPTI:CC News and Press, Optimi Health Corp. From 07/27/23

Stock Information
Company Name: Optimi Health Corp.
Stock Symbol: OPTI:CC
Market: CNQC
Website: optimihealth.ca
Menu
OPTI:CC OPTI:CC Quote OPTI:CC Short OPTI:CC News OPTI:CC Articles OPTI:CC Message Board
Get OPTI:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
OPTI:CC - Optimi Health Announces Receipt of Purported Termination Notice

VANCOUVER, British Columbia, July 27, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”) has received a termination notice and demand for payment pursuant to a definitive supply agreement (the “Supply A...
OPTI:CC - Optimi Health To Supply MDMA For Therapist Experiential Training Program at Numinus, Supported by MAPS

VANCOUVER, British Columbia, June 15, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. ( CSE: OPTI ) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), an end-to-end drug researcher and formulator licensed by Health Canada to produce and supply, for clinical re...

OPTI:CC - Optimi Health Completes Harvest Of Psilocybe Cubensis For Delivery To The Australian Medical Market

VANCOUVER, British Columbia, May 17, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. ( CSE: OPTI ) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), an end-to-end drug researcher and formulator licensed by Health Canada to produce and supply, for clinical res...

OPTI:CC - Optimi Health Granted Natural Health Product Site Licence By Health Canada

VANCOUVER, British Columbia, May 10, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp . ( CSE: OPTI ) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), an end-to-end drug researcher and formulator licensed by Health Canada to produce and supply, for clinica...
OPTI:CC - Optimi Health Announces CAD$1.2 Million GMP Psilocybin Supply Agreement for Clinical Research and Development

VANCOUVER, British Columbia, May 04, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“ Optimi ” or the “ Company ”), today announced that it has entered into a CAD$1.2 million definitive supply agreement with a private entity...

OPTI:CC - Micro Cap Soars On Distribution Agreement

A Vancouver-based micro cap saw it’s shares rally strongly on Wednesday after it was announced that the company has entered into a long-term distribution agreement with Mind Medicine Australia (“MMA”), a leading charitable organization and patient advocacy group seeking to al...

OPTI:CC - Optimi Health Enters Australian Medical MDMA And Psilocybin Market With Mind Medicine Australia Distribution Agreement

Highlights: Signed Purchase Orders with Mind Medicine Australia to ensure that patients with treatment resistant post-traumatic stress disorder (PTSD) have access to medical grade GMP MDMA (using Optimi Health’s MDMA formulation, OPTI-MHCL) and patients with treatment resistant d...
OPTI:CC - CSE Bulletin: Expiry - Optimi Health Corp. 24FEB2023 Warrants (OPTI.WT)

Toronto, Ontario--(Newsfile Corp. - Le 22 février/February 2023) - Optimi Health Corp. 24FEB2023 Warrants listed on February 25, 2021 will expire on February 24, 2023. Settlement Terms: All trades February 22 and 23 will settle for cash next day. Trades on February 24, 2023 will be for ...

OPTI:CC - Optimi Health Submits Phase I Clinical Trial Application Combining The Use Of Proprietary Psilocybin and MDMA Drug Candidates In Healthy Therapists

VANCOUVER, British Columbia, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. ( CSE: OPTI ) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), an end-to-end Canadian-based drug manufacturer and formulator licensed by Health Canada to produce and su...

OPTI:CC - Optimi Health Completes First Production of Novel MDMA Drug Candidate OPTI-MHCL

The Company is producing OPTI-MHCL in-house under its Health Canada issued Dealers Licence using Optimi’s scalable, proprietary production method. Optimi is also manufacturing MDMA under GMP-compliant protocols, making additional MDMA product available for clinical research, drug...
Previous 10 Next 10